標(biāo)題: Titlebook: Clinical Applications of Biomaterials; State-of-the-Art Pro Gurbinder Kaur Book 2017 Springer International Publishing AG 2017 Bone regener [打印本頁(yè)] 作者: Gram114 時(shí)間: 2025-3-21 16:15
書目名稱Clinical Applications of Biomaterials影響因子(影響力)
書目名稱Clinical Applications of Biomaterials影響因子(影響力)學(xué)科排名
書目名稱Clinical Applications of Biomaterials網(wǎng)絡(luò)公開度
書目名稱Clinical Applications of Biomaterials網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Clinical Applications of Biomaterials被引頻次
書目名稱Clinical Applications of Biomaterials被引頻次學(xué)科排名
書目名稱Clinical Applications of Biomaterials年度引用
書目名稱Clinical Applications of Biomaterials年度引用學(xué)科排名
書目名稱Clinical Applications of Biomaterials讀者反饋
書目名稱Clinical Applications of Biomaterials讀者反饋學(xué)科排名
作者: 茁壯成長(zhǎng) 時(shí)間: 2025-3-22 00:17
Variation in Properties of Bioactive Glasses After Surface Modification,ology, and biotechnology. The surface properties of biomaterials play a significant role in the interaction with the surrounding tissues. This chapter is mainly focused on bioactive silicate glasses, in the following three aspects: (1) ion doping glass, (2) covalent modification of a bioactive glass作者: 灰姑娘 時(shí)間: 2025-3-22 02:26 作者: Stricture 時(shí)間: 2025-3-22 07:04
Calcium Phosphate Cements for Medical Applications, apatite and brushite, are discussed. A description of the main properties (and testing methods) of CPCs such as setting time, cohesion time, mechanical properties and injectability and different strategies adopted to improve them are reported. The chapter includes a description of the preparation s作者: 友好關(guān)系 時(shí)間: 2025-3-22 08:44
Calcium Orthophosphate-Based Bioceramics and Its Clinical Applications, potential bone grafts due to their biomechanical properties. A bit later, such synthetic biomaterials were called bioceramics. In principle, bioceramics can be prepared from diverse inorganic substances but this review is limited to calcium orthophosphate (CaPO.)-based formulations only, which poss作者: atrophy 時(shí)間: 2025-3-22 12:52 作者: atrophy 時(shí)間: 2025-3-22 17:19 作者: 污點(diǎn) 時(shí)間: 2025-3-22 23:22 作者: violate 時(shí)間: 2025-3-23 01:33 作者: chandel 時(shí)間: 2025-3-23 07:44 作者: defibrillator 時(shí)間: 2025-3-23 13:01
Antibacterial Properties of Bioactive Glasses,uperior osteoconductivity and antibacterial characteristics in contrast to conventional (micron-sized) bioactive glass materials. The combination of bioactive glass nanoparticles with various ions like silver (Ag.), copper (Cu.), cerium (Ce.), zinc (Zn.) and various organic naturally occurring subst作者: flex336 時(shí)間: 2025-3-23 16:46
,Development of URIST? a Multiphasic rhBMP-2 Bone Graft Substitute, to stimulate spine fusion, repair of long bone non-unions and bone augmentation in the jaw..BMP implants are expensive and are associated with complications including ectopic bone formation, inflammation and cancer due to the very high doses of BMP used. These high doses are required due to the ine作者: Celiac-Plexus 時(shí)間: 2025-3-23 20:02
Development and In Vitro Analysis of a New Biodegradable PLA/Hydroxyapatite (HAp) Composite for Bioand scientific societies. Targeted and multidelivery of drug and key minerals to support bone repair and regeneration at the defect site, from flexible biodegradable devices at the rate within the therapeutic window, seem to be an effective strategy. However, the drug delivery vehicles available are作者: Additive 時(shí)間: 2025-3-23 23:14
Biomaterials for Cell Encapsulation: Progress Toward Clinical Applications,technique can also treat multiple diseases in the absence of immunosuppression. Over the past few years, the quality of life of patients has improved remarkably as a direct result of microencapsulation technology, as this technology eliminates the requirement of an immunosuppressant. However, much a作者: Peristalsis 時(shí)間: 2025-3-24 06:13 作者: 有毛就脫毛 時(shí)間: 2025-3-24 08:13 作者: 離開可分裂 時(shí)間: 2025-3-24 13:49
https://doi.org/10.1007/978-3-658-28091-8atible, bioactive, and osteoconductive materials having similar properties with the bone. In this review, the applications of tricalcium phosphate and hydroxyapatite in orthopedics are given in terms of graft, carrier, and coating materials.作者: Compatriot 時(shí)間: 2025-3-24 15:23
Review of the Regulatory Context,al properties and injectability and different strategies adopted to improve them are reported. The chapter includes a description of the preparation steps of a typical cement before implantation in the bone defect and some examples of current medical applications and limitations of CPCs.作者: 一窩小鳥 時(shí)間: 2025-3-24 22:47
Conclusions: Lessons for Trade Conflictremarkably as a direct result of microencapsulation technology, as this technology eliminates the requirement of an immunosuppressant. However, much additional research needs to be conducted in order to commercialize and clinically apply more widely this life-saving technology.作者: 笨拙處理 時(shí)間: 2025-3-24 23:55 作者: 使習(xí)慣于 時(shí)間: 2025-3-25 03:41
Calcium Phosphate Cements for Medical Applications,al properties and injectability and different strategies adopted to improve them are reported. The chapter includes a description of the preparation steps of a typical cement before implantation in the bone defect and some examples of current medical applications and limitations of CPCs.作者: 奇怪 時(shí)間: 2025-3-25 10:31 作者: seduce 時(shí)間: 2025-3-25 11:48
le also covering important areas such as the soft tissue replacement, apatites, bone regeneration and cell encapsulation. This book is appropriate for biomedical engineers, materials scientists, and clinicians who are seeking to implement the most advanced approaches and technologies with their patients.?978-3-319-85817-3978-3-319-56059-5作者: 小木槌 時(shí)間: 2025-3-25 19:05 作者: 強(qiáng)制令 時(shí)間: 2025-3-25 20:59
Palgrave Studies in European Union Politics used for drug delivery. In addition, it is reported how the physical-chemical aspects of polymeric matrixes and bioactive glasses play an important role on the design of new carrier systems. At the final of this chapter, practical examples are covered, and a special section of clinical applications is discussed.作者: Airtight 時(shí)間: 2025-3-26 03:58
Palgrave Studies in European Union Politics Current commercial dental glass-ceramics are explained, and also selected papers that address promising types of dental glass-ceramics are reviewed. Finally, we include trends on relevant open issues and research possibilities.作者: 寡頭政治 時(shí)間: 2025-3-26 06:07 作者: glisten 時(shí)間: 2025-3-26 12:07
Lina M. Svedin,Adam Luedtke,Thad E. Hallustained release. We have demonstrated in a series of non-clinical studies that URIST can produce more bone with less BMP than the currently approved collagen carrier. Further in a large animal model we demonstrate that URIST is safe and effective for alveolar ridge augmentation.作者: Slit-Lamp 時(shí)間: 2025-3-26 13:39 作者: MAIZE 時(shí)間: 2025-3-26 17:21
Variation in Properties of Bioactive Glasses After Surface Modification,tion by silanes is to improve the interaction with the surrounding bone tissue, to enhance dispersion stability of inorganic particles in various liquids, or to act as anchors for the immobilization of drugs. Biological functionalization of bioactive glasses can improve their bone integration.作者: 草本植物 時(shí)間: 2025-3-26 22:03 作者: 破譯密碼 時(shí)間: 2025-3-27 01:45 作者: Aspirin 時(shí)間: 2025-3-27 06:36
Antibacterial Properties of Bioactive Glasses,these materials, their application, type of bioactive glasses, factors that play a vital role in enhancing their antibacterial properties against various bacterial traits and a brief detail of techniques applied to carry out antibacterial studies of nanosized bioactive glasses.作者: 忍受 時(shí)間: 2025-3-27 10:49
,Development of URIST? a Multiphasic rhBMP-2 Bone Graft Substitute,ustained release. We have demonstrated in a series of non-clinical studies that URIST can produce more bone with less BMP than the currently approved collagen carrier. Further in a large animal model we demonstrate that URIST is safe and effective for alveolar ridge augmentation.作者: 多山 時(shí)間: 2025-3-27 15:39
Development and In Vitro Analysis of a New Biodegradable PLA/Hydroxyapatite (HAp) Composite for Biooptions to mitigate MSDs problem. In vitro analysis of the developed devices is a vital step towards clinical trial and commercialization of the implant. Different approach and results have been compared to draw guidelines for the development and testing of thin film composite applications as a slow drug delivery vehicle.作者: Lyme-disease 時(shí)間: 2025-3-27 20:49
Book 2017ry, diabetes, neurodegenerative diseases and cranioplasty implants. Expert contributors analyze biomaterials such as calcium phosphate, sol-gel and quenched glasses, metallic and polymer implants, bioactive glass, and polymer composites while also covering important areas such as the soft tissue rep作者: PHAG 時(shí)間: 2025-3-27 22:36 作者: 夾克怕包裹 時(shí)間: 2025-3-28 03:35 作者: 榨取 時(shí)間: 2025-3-28 09:56 作者: 新陳代謝 時(shí)間: 2025-3-28 11:29
Risk Regulation in the Single Marketperiods..The chapter is organized in four sections. The first one deals with synthesis and mechanism of formation of mesoporous bioactive glasses. The second one analyses the bioactive behavior. The third one is devoted to understand the specificity of bioactive response induced by the mesoporous st作者: 行乞 時(shí)間: 2025-3-28 17:41 作者: Indecisive 時(shí)間: 2025-3-28 20:20
How Did Bioactive Glasses Revolutionize Medical Science? A Tribute to Larry Hench,globe. Bioactive glasses are excellent examples of biomaterials for clinical applications owing to their high biocompatibility, bioactivity, and flexibility in compositional design and properties. The invention of Bioglass? by Prof. Larry Hench magnificently revolutionized the medical industry. Foll作者: MUTE 時(shí)間: 2025-3-28 23:18
Calcium Orthophosphate-Based Bioceramics and Its Clinical Applications,ontrols, it became possible to choose whether the CaPO.-based implants remain biologically stable once incorporated into the skeletal structure or whether they were resorbed over time. At the turn of the millennium, a new concept of regenerative bioceramics was developed and such formulations became作者: 暫時(shí)休息 時(shí)間: 2025-3-29 06:59 作者: placebo-effect 時(shí)間: 2025-3-29 10:37 作者: 首創(chuàng)精神 時(shí)間: 2025-3-29 12:21 作者: 孵卵器 時(shí)間: 2025-3-29 16:41
https://doi.org/10.1007/978-3-319-56059-5Bone regeneration; Orthopaedic applications; Sol-gel; Metallic and polymer implants; Soft tissue replace作者: GUMP 時(shí)間: 2025-3-29 22:42
978-3-319-85817-3Springer International Publishing AG 2017作者: 被告 時(shí)間: 2025-3-30 00:23
Unternehmensführung & Controllingmanufacturing companies are investing in the production, development, and commercialization of new biomaterial products. The biomaterials industry is a large contributor to the overall market for medical technology, resulting in approximately $42 billion in annual sales with an anticipated growth ra作者: 維持 時(shí)間: 2025-3-30 04:37 作者: stress-response 時(shí)間: 2025-3-30 11:20
https://doi.org/10.1007/978-3-658-28091-8roperties with the bone and can be used in different application. Particularly, beta-tricalcium phosphate (β-TCP) and hydroxyapatite (HAp) are biocompatible, bioactive, and osteoconductive materials having similar properties with the bone. In this review, the applications of tricalcium phosphate and作者: 結(jié)合 時(shí)間: 2025-3-30 12:40
Review of the Regulatory Context, apatite and brushite, are discussed. A description of the main properties (and testing methods) of CPCs such as setting time, cohesion time, mechanical properties and injectability and different strategies adopted to improve them are reported. The chapter includes a description of the preparation s
